Riders and trainers believe that oral maltodextrin (MD) supplementation prior to exercise increases blood glucose availability and delay the onset of fatigue in horses, although there is no evidence supporting this claim. Therefore, we aimed to evaluate the effect of MD supplementation on blood glucose, L-lactate, insulin, cortisol levels, and heart rate in horses subjected to an incremental exercise test. A randomized placebocontrolled crossover trial was designed to test the effect of three doses of MD (50, 100 and 200 g) on blood glucose, L-lactate, insulin, cortisol levels, and heart rate of four Purebred Lusitanian geldings. A seven-step incremental field exercise test was used; the initial speed was set at 2.5 m/s, followed by 3.3 m/s, 4.1 m/s, 5.0 m/s, 6.6 m/s, 
Introduction
Oral carbohydrate (CHO) supplementation is a nutritional strategy widely adopted across many equestrian disciplines. Trainers and riders believe that increased blood glucose availability leads to enhanced endurance performance, and rapid post-exercise recovery. This belief is probably an erroneous extrapolation from the study of Farris et al. (1995) , who showed that intravenous glucose infusion increased blood glucose availability and delayed the onset of fatigue in horses during submaximal exercise on a treadmill. Furthermore, oral supplementation with combined glucose and fructose effectively increased glucose availability during low-intensity exercise in horses (Bullimore et al., 2000) .
In addition to simple carbohydrates, products of starch hydrolysis, known as maltodextrins (MD), which are classified as complex carbohydrates with a high glycemic index, have attracted attention within the field of human sports nutrition (Chronakis, 1998) . MD supplementation prior and during biathlons was shown to prevent exercise-induced hypoglycemia, without increasing blood insulin and cortisol levels (Mamus et al., 2006) .
Although the effect of riding exercise on equine glucose, insulin, and cortisol levels is well documented (Gordon et al., 2007; Strzelec et al., 2011) , there is limited evidence to suggest that MD increases glucose availability in exercising horses without altering cortisol and insulin levels. A previous study showed that MD is well absorbed and may replace starch content in equine diets (Nunes Gil et al., 2012) , but this study was performed in horses at rest and did not measure insulin and cortisol responses during exercise.
Although commercial MD products are currently available on the market, neither the efficacy nor the biosafety of these products have been demonstrated. Therefore, the aim of this study was to evaluate the effects of MD supplementation on blood glucose, L-lactate, insulin, cortisol levels, and heart rate in horses subjected to an incremental exercise test. We hypothesized that MD supplementation will increase glucose availability and enhance the horses' ability to maintain its power output during exercise.
respectively. In conclusion, MD supplementation increased serum cortisol levels and showed no effect on heart rate, blood glucose, L-lactate, and serum insulin levels in horses submitted to an incremental exercise test. 87,63 ± 3,25 mg/dL, 78,33 ± 10,08 mg/dL, e 95,18 ± 14,73 mg/dL, respectivamente, enquanto and the last two steps (6.6 m/s and 8.4 m/s) were completed at gallop.
Kewyords
Sound markers were used to alert the rider to maintain a specific velocity at each step. The interval between consecutive sound markers was calculated, and outcomes were processed using audio mixer software (MixPad Recording Software © -Greenwood Village, USA).
The racetrack had a squared design: four straight lines, each one measuring 40 m with curved lines at each vernicle. The racetrack surface was covered with 20 cm of dry sand, and smoothened prior to the exercise test.
The exercise test and sample collection were performed in the morning (9 -12 AM).
Sample collection and processing
Blood samples were collected from the jugular vein at rest, and during the last 15 s of each step of the test (2.5 m/s, 3.3 m/s, 4.1 m/s, 5.0 m/s, 6.6 m/s, and 8.4 m/s). Blood samples were divided into sodium fluoride-containing tubes and tubes without the anticoagulant and centrifuged (5,000 RPM, 10 min.); plasma/serum aliquots were stored at -80 °C.
Plasma L-lactate and glucose concentrations were analyzed through colorimetric and hexokinase methods, respectively, using an automated analyzer (Randox
Material and methods

Study design
This was a randomized, placebo controlled, crossover trial evaluating the effects of three doses of MD (50, 100 and 200 g) against a placebo (water), which were orally administered prior to an incremental exercise test. The variables heart rate, blood glucose, lactate, insulin, and cortisol levels were evaluated. The order of the treatments was stochastically defined and the washout period was defined as 14 days.
Animals and ethics
Four Purebred Lusitanian geldings were used for this study (each aged 3 -4 years old, weighing 480 ± 20 kg). The animals were housed in individual boxes (3 × 3 × 5 m), and regularly fed hay and commercial feed. The horses were clinically sound at the onset of the experiment, and conditioned for dressage competitions. The study was approved by the Animal Research Ethics Committee of the University of São Paulo, School of Veterinary Medicine and Animal Science (protocol n. 7256300114).
Nutritional intervention and exercise testing
Maltodextrin-water solution was orally administered 30 min before a standardized exercise test. Three doses of pure MD (Galena Quimica e Farmaceutica © -Campinas, Brazil) (50, 100 and 200 g) were diluted in warm water (60 mL) prior to administration. Placebo solution (only water) was also used. The tip of a 20 mLsyringe was cut to enable the administration of maltodextrin-water solution, which viscosity implies certain resistance.
After oral administration, the horses completed an incremental exercise test in a field comprising seven discrete steps; the initial speed was set at 2.5 m/s, followed by 3.3 m/s, 4.1 m/s, 5.0 m/s, 6.6 m/s, and 8.4 m/s, where the same rider was used. Each step lasted 3 min (initial 2 min and 45 s of exercise and 15 s at rest for blood collection). The first step (2.5 m/s) was performed at walk, followed by 3 steps at trot (3.3 m/s, 4.1 m/s and 5.0 m/s), differences between the groups were tested for each outcome using a one-way analysis of variance (ANOVA). A repeated measures ANOVA was performed to test the main effects of "group," "speed," and "interaction (group*speed)," using a significance level of 5%. Both "group" and "speed" were set as fixed factors, and "horses" was set as a random factor. Tukey's test was performed for post hoc analysis. Data are presented in the table and graphic as mean ± standard deviation. Pearson's correlation analysis was performed for the whole set of variables at a significance level of 1%.
Results and discussion
Blood glucose, blood L-lactate, serum insulin, serum cortisol, and heart rate were within the reference range at rest, and there were no differences among groups. Blood glucose, blood L-lactate, serum insulin levels, and the heart rate did not differ among groups during the exercise test; the serum cortisol concentrations of the supplemented groups (50, 100 and 200 g) were higher than placebo group (0 g) (p < 0,01) ( Figure 1 and Table 1 ). Furthermore, horses supplemented with 200g of MD showed the highest serum cortisol levels (5.54 ± 4.73 mmol/L) at the last step of the test (8,4 m/s), which is 4.5 times greater than horses supplemented with placebo, at the same step (8,4 m/s; serum cortisol equal to 1.20 ± 0.53 mmol/L).
The main finding of this preliminary study was that MD supplementation did not significantly affect the blood glucose levels in horses engaged in the incremental exercise test. This observation disagrees with previous studies performed in resting horses (Nunes Gil et al., 2012) , and in exercising humans (Mamus et al., 2006) , which supports the association between MD supplementation and increased blood glucose availability. The remarkable sympathetic response to intense exercise, which has been previously described in horses (Snow et al., 1992) , may play an important role in MD supplementation. Circulating catecholamine acts on blood flow redistribution, muscle and liver glycogen breakdown, GLUT-4 activity, and glucose oxidation rate (Richter and Hargreaves, 2013) . These physiological changes indicate that a specific metabolic set takes place during exercise to prioritize muscle demands over other functions such as digestion and absorption. Recently, CHO absorption during exercise has aroused the interest of researchers; studies in athletes indicate that the gut is able to adapt to nutritional training and improve nutrients delivery during exercise (Jeukendrup, 2017) .
The reduced amount of MD administered to our experimental units may also account for the reported gap between MD supplementation and glucose availability. Nunes Gil et al. (2012) administered 800 -2500 g of MD following an adaptation period, and observed expected effects on blood glucose and insulin levels. According to the authors' knowledge, there is a lack of consensus in the literature regarding the optimum amount of MD supplementation for horses prior to exercise. However, based on previous studies evaluating CHO intake in humans (3.0 g/kg) (Potgieter, 2013) , even the upper limits of CHO supplementation (200 g) had negligible effects on glucose levels, and higher doses could still be investigated. We report an exponential increase in L-lactate concentration following the first half of the test, which was likely due to type II muscle fiber recruitment and increased rate of anaerobic glycolysis. Blood L-lactate and heart rate response to submaximal exercise test, as observed in this study, agree with several studies that used the field exercise protocol to evaluate fitness and performance in Thoroughbred (Evans, 2007) , Arabian (Goachet and Julliand, 2015) , and Warmblood sport horses (Munsters et al., 2014) , as well as in Mangalarga Marchador horses (Bogossian et al., 2017) . This agreement suggests that the Purebred Lusitanian breed would also be an interesting model for future investigations in sport nutrition.
Insulin levels were unchanged with speed or nutritional intervention in this study; graphical analyses suggest that speed "grouped" the data, attenuating apparent baseline difference. Starch replacement by MD in resting horses showed a positive effect on insulin (Nunes Gil et al., 2012) , although, as cited elsewhere, the smaller amount of MD used in our study might account for this difference.
Finally, previous studies on exercise-induced hypercortisolemia suggested that there was a positive association between high-intensity exercise and increased salivary cortisol levels in horses (Strzelec et al., 2011) and in humans (Jacks et al., 2002) . Our exercise protocol involved only submaximal intensities and was unlikely to elicit a stress response. We show that the effects of nutritional intervention on cortisol levels (group effect) in horses fails to conform to the previously accepted consensus that cortisol secretion during exercise in humans functions as a metabolic response for glucose homeostasis (MacLaren et al., 1999; Lane et al., 2010) . Future studies will investigate the association between glucose availability and cortisol secretion in horses.
Conclusion
Maltodextrin supplementation increased serum cortisol levels and showed no effect on heart rate, blood glucose, L-lactate and serum insulin levels in horses subjected to an incremental exercise test.
